IT8123270A0 - Imidazol-eteri ed esteri, procedimenti per prepararli e composizioni farmaceutiche che licontengono. - Google Patents

Imidazol-eteri ed esteri, procedimenti per prepararli e composizioni farmaceutiche che licontengono.

Info

Publication number
IT8123270A0
IT8123270A0 IT8123270A IT2327081A IT8123270A0 IT 8123270 A0 IT8123270 A0 IT 8123270A0 IT 8123270 A IT8123270 A IT 8123270A IT 2327081 A IT2327081 A IT 2327081A IT 8123270 A0 IT8123270 A0 IT 8123270A0
Authority
IT
Italy
Prior art keywords
eters
imidazol
esters
procedures
preparing
Prior art date
Application number
IT8123270A
Other languages
English (en)
Other versions
IT1168008B (it
Inventor
Carenzi Angelo
Chiarino Dario
Della Bella Davide
Frigeni Viviana
Veneziani Carlo
Original Assignee
Bresso Milano A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bresso Milano A filed Critical Bresso Milano A
Publication of IT8123270A0 publication Critical patent/IT8123270A0/it
Priority to IT23270/81A priority Critical patent/IT1168008B/it
Priority to CA000408135A priority patent/CA1186315A/en
Priority to AT82200960T priority patent/ATE56707T1/de
Priority to DE8282200960T priority patent/DE3280245D1/de
Priority to EP82200960A priority patent/EP0074130B1/en
Priority to ZA825428A priority patent/ZA825428B/xx
Priority to PT75338A priority patent/PT75338B/pt
Priority to ES515895A priority patent/ES515895A0/es
Priority to GR68908A priority patent/GR76886B/el
Priority to DK341882A priority patent/DK158944C/da
Priority to AU86605/82A priority patent/AU557494B2/en
Priority to JP57133002A priority patent/JPS5849369A/ja
Priority to US06/591,243 priority patent/US4560696A/en
Application granted granted Critical
Publication of IT1168008B publication Critical patent/IT1168008B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
IT23270/81A 1981-07-31 1981-07-31 Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono IT1168008B (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT23270/81A IT1168008B (it) 1981-07-31 1981-07-31 Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono
CA000408135A CA1186315A (en) 1981-07-31 1982-07-27 Process for the preparation of new imidazole compounds and some intermediates useful in their preparation
AT82200960T ATE56707T1 (de) 1981-07-31 1982-07-27 Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
DE8282200960T DE3280245D1 (de) 1981-07-31 1982-07-27 Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
EP82200960A EP0074130B1 (en) 1981-07-31 1982-07-27 New imidazole compounds, process for the preparation thereof and pharmaceutical compositions containing them
PT75338A PT75338B (en) 1981-07-31 1982-07-28 Process for the preparation of imidazole compounds havin a pharmaceutical effect
ZA825428A ZA825428B (en) 1981-07-31 1982-07-28 New imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them
ES515895A ES515895A0 (es) 1981-07-31 1982-07-30 "un procedimiento para la preparacion de un compuesto de imidazol".
GR68908A GR76886B (it) 1981-07-31 1982-07-30
DK341882A DK158944C (da) 1981-07-31 1982-07-30 Analogifremgangsmaade til fremstilling af substituerede methylimidazolforbindelser
AU86605/82A AU557494B2 (en) 1981-07-31 1982-07-30 2-substituted-5-arylimidazoles
JP57133002A JPS5849369A (ja) 1981-07-31 1982-07-31 新規のイミダゾール化合物
US06/591,243 US4560696A (en) 1981-07-31 1984-03-20 Analgesic, antipyretic or anti-inflammatory imidazole compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23270/81A IT1168008B (it) 1981-07-31 1981-07-31 Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
IT8123270A0 true IT8123270A0 (it) 1981-07-31
IT1168008B IT1168008B (it) 1987-05-20

Family

ID=11205498

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23270/81A IT1168008B (it) 1981-07-31 1981-07-31 Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono

Country Status (13)

Country Link
US (1) US4560696A (it)
EP (1) EP0074130B1 (it)
JP (1) JPS5849369A (it)
AT (1) ATE56707T1 (it)
AU (1) AU557494B2 (it)
CA (1) CA1186315A (it)
DE (1) DE3280245D1 (it)
DK (1) DK158944C (it)
ES (1) ES515895A0 (it)
GR (1) GR76886B (it)
IT (1) IT1168008B (it)
PT (1) PT75338B (it)
ZA (1) ZA825428B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206257A (en) * 1987-03-05 1993-04-27 May & Baker Limited Pesticidal method using 2-phenylimidazole derivatives
EP0609457B1 (en) * 1992-07-20 1997-10-29 Eisai Co., Ltd. Benzene derivative
US6613789B2 (en) 1994-07-28 2003-09-02 G. D. Searle & Co. Heterocyclo-substituted imidazoles for the treatment of inflammation
US5616601A (en) * 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
AR024222A1 (es) * 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
ES2243337T3 (es) 1999-12-16 2005-12-01 Schering Corporation Imidazoles sustituidos antagonistas del receptor y5 del neuropeptido y.
ES2159489B1 (es) * 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.
CN102775354A (zh) * 2011-05-10 2012-11-14 无锡立诺康医药科技有限公司 一种合成4-芳基-5-羧酸咪唑及其酯的工艺方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570212A (en) * 1975-10-29 1980-06-25 Smithkline Corp Imidazoles
US4104473A (en) * 1976-04-23 1978-08-01 Shikoku Chemicals Corporation Novel imidazole compounds and process for preparations thereof
US4124766A (en) * 1977-02-03 1978-11-07 American Cyanamid Company Substituted 3-(4-imidazolylmethylene)carbazic and thiocarbazic acid esters
US4139708A (en) * 1977-05-24 1979-02-13 Sk&F Lab Co. Intermediates and processes useful for preparing medicinal agents imidazolemethylphosphonium salts
KR810000359B1 (ko) * 1980-03-31 1981-04-22 한국과학기술원 히드록시메틸이미다졸 화합물의 제조방법

Also Published As

Publication number Publication date
IT1168008B (it) 1987-05-20
JPH0337549B2 (it) 1991-06-05
ES8403463A1 (es) 1984-04-01
PT75338B (en) 1985-01-04
US4560696A (en) 1985-12-24
DK158944C (da) 1991-01-21
DK158944B (da) 1990-08-06
EP0074130A2 (en) 1983-03-16
CA1186315A (en) 1985-04-30
ES515895A0 (es) 1984-04-01
GR76886B (it) 1984-09-04
DK341882A (da) 1983-02-01
EP0074130B1 (en) 1990-09-19
AU557494B2 (en) 1986-12-24
PT75338A (en) 1982-08-01
DE3280245D1 (de) 1990-10-25
JPS5849369A (ja) 1983-03-23
AU8660582A (en) 1983-02-03
ZA825428B (en) 1983-08-31
EP0074130A3 (en) 1983-08-10
ATE56707T1 (de) 1990-10-15

Similar Documents

Publication Publication Date Title
IT8248157A0 (it) Composti aril-ciclobutil-amminici sostituiti, procedimenti per prepararli, composti intermedi e composizioni farmaceutiche che li contengono
EP0112852A4 (en) PHARMACEUTICAL GEL COMPOSITION.
GB2195889B (en) Pharmaceutical antioxidant composition produced from plants.
EP0302900A4 (en) MEDICINAL PRODUCTS WITH REPRESENTED TASTE.
IT8422413A0 (it) Esteri di polioli, loro preparazione e loro impiego.
IT8020961A0 (it) Procedimento per purificare esteri.
IT8026587A0 (it) Eteri basici, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
NL8300934A (nl) Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
IT8348155A0 (it) Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
IT8548093A0 (it) Eteri amminociclopentilici, procedimento per prepararli e composizione farmaceutica che li comprende
IT8123270A0 (it) Imidazol-eteri ed esteri, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
IT8424159A0 (it) Composizioni farmaceutiche antitumorali e procedimento per laloro preparazione.
IT8219392A0 (it) Composizioni ad elevata durezza eprocedimento per prepararle.
IL62747A (en) 2-guanidinothiazole derivatives,process for the preparation thereof and pharmaceutical compositions comprising the same
DE3164568D1 (en) Kijanimicin, pharmaceutical compositions containing it and processes for preparing kijanimicin and the compositions
IT8719700A0 (it) 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono.
IT8221678A0 (it) Esteri basici ad attivita'calcioantagonista, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT8448800A0 (it) Amminociclopentani, composizioni farmaceutiche che li contengono eprocedimento per la loro preparazione
IT8121298A0 (it) Nitroimidazoli ad attivita'tricomonacida, procedimento per laloro preparazione e relative composizioni farmaceutiche.
DE3167471D1 (en) Benzoquinolizines, processes for their preparation and pharmaceutical compositions
IT8348067A0 (it) Cianoguanidine, procedimento per ottenerle e composizioni farmaceutiche che le contengono
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
IT8422177A0 (it) Procedimento per la preparazione di esteri.
IT8123860A0 (it) 4-carbamoilossi-ossazafosforine metodo per produrle e preparazioni farmaceutiche che le contengono.
IT8349380A0 (it) Antibiotici, cefalosporinici, procedimento per prepararli e composizioni farmaceutiche che li contengono